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Abstract  
It is well established that numerous factors can affect the rate at which we age biologically. Diet, 
physical activity, lifestyle and our genes all play a major role in influencing the ageing trajectory and 
longevity. Major trauma affects millions globally, is the major cause of death in young adults and could 
influence ageing processes but has largely been ignored by biogenterologists. The long-term health 
consequences of physical trauma are well known in the medical community, how trauma effects the 
ageing process at a molecular level is not. It has long been difficult to assess ageing trajectories due to 
the absence of a biomarker of biological rather than chronological age. Recent advances in epigenetics 
have helped by identifying specific DNA methylation sites as good indicators of biological age. Recent 
investigations into the impact of psychological trauma and the associated physical stress on 
accelerating ageing as measured by epigenetic drift are promising. The physical and metabolic stress 
which is synonymous with physical trauma may also accelerate the ageing process. We suggest that 
long term epigenetic profiling is required to understand to what degree the ageing trajectory is altered 
by trauma, which will in turn add support for the development of novel therapies to improve health 
outcomes for survivors of traumatic injury. 
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1. Introduction  
With average life expectancy rising from the mid 40’s to mid-70’s within the past 250 years, the global 
population has never been older. This increase in lifespan is even greater within western Europe and 
some Asian countries where the average life expectancy is now reaching the early to mid-80s, with 
Japan still leading the world with a life expectancy at birth for both genders of 83.7 (WHO, 2017). 
Although average lifespan is increasing, the period of life spent in good health, termed healthspan, 
has not kept pace, with people now spending longer portions of their life in ill health (Public Health 
England, 2016). Understanding the factors influencing the ageing trajectory is required if we are to be 
better equipped to deal with the effects of demographic change. Whilst genetics and lifestyle have 
received much attention as influencers of the ageing trajectory (Khaw et al., 2008; Steves et al., 2012), 
there are other factors largely beyond our control that can have a devastating impact on health across 
the life course. Here we consider the potential impact of major trauma on the ageing trajectory and 
ageing processes. 
1.1 Ageing as a malleable process 
Ageing is perhaps best described as an increased inability with time to cope with biological stress 
resulting in increased risk of disease and death. The biological changes which occur during ageing and 
drive the aged phenotype have been referred to as the ‘hallmarks of ageing’ and were described in a 
landmark paper by Lopez-Otin and colleagues (Lopez-Otin et al., 2013). This paper described processes 
as either core drivers or downstream mediators of the ageing process. The upstream processes 
initiating ageing are suggested to be genomic instability, telomere attrition, loss of proteostasis and 
epigenetic changes and the more downstream effectors include mitochondrial dysfunction, cell 
senescence, loss of stem cell function and inflammation (Lopez-Otin et al., 2013). All of these increase 
in prevalence with age and counteracting any of these processes extends lifespan and health span in 
a range of species (Colman et al., 2009; Newgard and Sharpless, 2013; Tchkonia et al., 2013).  
Aging is characterized by a progressive loss of physiological integrity, leading to impaired function and 
increased vulnerability to death. This deterioration is the primary risk factor for major human 
pathologies, including cancer, diabetes, cardiovascular disorders, and neurodegenerative diseases. 
Aging research has experienced an unprecedented advance over recent years, particularly with the 
discovery that the rate of aging is controlled, at least to some extent, by genetic pathways and 
biochemical processes conserved in evolution. This review enumerates nine tentative hallmarks that 
represent common denominators of aging in different organisms, with special emphasis on 
mammalian aging. These hallmarks are: genomic instability, telomere attrition, epigenetic alterations, 
loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, 
stem cell exhaustion, and altered intercellular communication. A major challenge is to dissect the 
interconnectedness between the candidate hallmarks and their relative contributions to aging, with 
the final goal of identifying pharmaceutical targets to improve human health during aging, with 
minimal side effects (Lopez-Otin et al., 2013). 
Ageing has been shown to be a malleable process with the ageing trajectory showing a high degree of 
plasticity. Ageing in humans is affected in large part by lifestyle choices, disease and environmental 
factors. Physical activity for example is able to preserve the function of major body systems, including 
the musculoskeletal (Pollock et al., 2015) and immune systems into old age (Duggal et al., 2018), 
fasting and calorie restriction have also been shown to reduce both inflammation and the 
accumulation of senescent cells (Blagosklonny, 2010; Cuervo et al., 2005) and extend both life and 
health span in primates (Colman et al., 2009). The malleability of longevity has also been 
demonstrated using compounds such as rapamycin, resveratrol and metformin which target the core 
ageing processes directly to extend life span in mice and other model organisms (Harrison et al., 2009; 
Mouchiroud et al., 2010). Conversely, various biomarkers of ageing appear to be accelerated with poor 
lifestyle, including increased senescent cells with obesity (Schafer et al., 2016) and raised systemic 
inflammation with obesity and inactivity (DeBoer, 2013).  
Ageing has thus been shown to be a variable process which is affected by virtually every aspect of life. 
Despite this, one external factor that can have a significant impact on both lifespan and healthspan, 
which has so far received little attention from biogerontologists, is major trauma. Trauma, whether 
physical or emotional is generally described as an injury or damage to a biological organism or to the 
psyche of an organism as a result of a traumatic event such as blunt force trauma, burn or exposure 
to combat. These kinds of events can have long term impacts on health in later life as well as longevity, 
regardless of how well the person initially recovers from their injury.  
2. Impact of major trauma on morbidity and mortality  
According to the World Health Organisation, death from injury accounts for 10% of annual global 
deaths, equivalent to approximately 5.8 million people (WHO, 2010). Trauma disproportionately 
affects the young, being the leading cause of death for under 45s in the US (Lenz et al., 2007). While 
5.8 million is an extremely large number of people, a much greater number are injured and survive, 
providing a new challenge to medicine to improve the long-term health of victims of traumatic injury.  
Perhaps the most apparent long-term impact of surviving a major traumatic injury is the resulting long-
term disability experienced by many patients. Evans et al, studied the prevalence of disability following 
trauma in a cohort of 109 young adults in the UK (90 male, aged 16-31 years) who were admitted to 
hospital with an injury severity score of >15. Of the 109 young adults admitted during the study 80% 
experienced a disability which affected their daily activities 5 years post-injury (Evans et al., 2003). 
Importantly, surviving an injury may have long term health consequences that go beyond being left 
with a disability. Casey and Ballantyne investigated the impact of sustaining a workplace injury on the 
development of chronic disease (Casey and Ballantyne, 2017) using data on 251 women and 243 men 
in the ‘Canadian community health survey’ who were injured between the 2003 and 2008/9 surveys. 
The prevalence of chronic disease was compared between the injured and non-injured cohorts 
(n=4495). The study revealed that 5 years after sustaining a workplace injury the injured workers 
developed chronic health conditions, including migraine headaches, arthritis, hypertension, asthma, 
intestinal or stomach ulcers, depression/mood problems, back problems and urinary or bowel 
disorders at a significantly higher incidence than their matched controls. The authors conclude by 
stating that obtaining a workplace injury is sufficient to increase the risk of developing chronic (often 
age associated) diseases. This is in line with the observation that around 16 percent off all disease 
burden globally is the result of an injury (Krug et al., 2000). 
Several retrospective analyses of linked hospital morbidity data for over 30,000 patients admitted with 
a burn injury between 1980 and 2012 in Western Australia by Duke and co-workers revealed increased 
admissions for a broad range of age-related conditions including cardiovascular disease (Duke et al., 
2017), diabetes  (Duke et al., 2016) and musculoskeletal conditions (Randall et al., 2015). These studies 
all suggest a long term impact on health after surviving a major injury. 
Not only does major injury increase the risk of chronic disease, there is a growing literature providing 
evidence that a major traumatic injury may also have a negative impact on long term survival. Duke 
and colleagues also carried out two retrospective analyses of mortality rates in adults aged below and 
above 45 years with a burn injury using the hospital records of 6,014 patients and 25,759 matched 
controls. The data revealed increased mortality rate ratios of 1.4 in the over 45 years group and 1.8 in 
the under 45s (Duke et al., 2015a, 2015b). It is claimed in the papers that these results are likely an 
underestimate of the impact of burn injury on mortality as the data included in hospital deaths. The 
authors suggested that the deaths occurring after discharge from hospital were potentially due to 
prolonged oxidative stress, hormone dysregulation and an increased risk of cancer due to the chronic 
hypermetabolic state often present for years following thermal injury.  
In another study investigating the impact of traumatic brain injury (TBI) Brooks et al showed in a large-
scale study (N=7228) across 20 US hospitals, that after a TBI men aged 40 or under had a 10% increase 
in mortality over a 20-year period compared to a control population (Brooks et al., 2013).This supports 
the conclusion of earlier studies which also found that long-term there is a significant increase in 
mortality among those who have received a TBI (Brown et al., 2004). 
What these findings, and the literature more generally show is that an adverse physical injury, whether 
resulting in disability or not, has the potential to increase risk of disease and death, possibly due in 
part to an acceleration of the ageing process. 
3. How might trauma impact ageing processes?  
While the exact mechanisms responsible for increasing the risk of disease and mortality following 
trauma are yet to be fully elucidated, it is likely that there are multiple processes at work, many of 
which may be common between the trauma response and the ageing process. Thermal injury and 
many forms of trauma result in a cascade of metabolic changes which result in increased oxidative 
stress, inflammation, multiorgan stress, tissue loss, changes to body composition and increasing frailty 
(Duke et al., 2015b). These changes are often associated with ageing and the immediate response of 
the body to trauma includes processes that also drive ageing, including inflammation, metabolic 
dysregulation and epigenetic changes.  
3.1 The inflammatory response to trauma 
One common factor between ageing and the response to trauma is inflammation. There is a growing 
consensus within the literature that inflammation, as well as being a symptom of ageing, may also be 
one of the driving forces behind it. The chronic inflammation that develops and persists as we age has 
been dubbed ‘inflammaging’ (Franceschi, 2008). As we age there is an increase in chronic low-grade 
inflammation, with raised serum levels of pro-inflammatory cytokines such IL6, TNFα and CRP and 
reduced levels of anti-inflammatory cytokines such as IL10. The presence and amount of inflammaging 
is associated with increased mortality (Franceschi et al., 2007) as well as age-related frailty (Baylis et 
al., 2014) and disease (Chung et al., 2009; Franceschi and Campisi, 2014).  
There are many factors influencing inflammaging including environmental factors such as physical 
inactivity (Ford, 2002), adiposity (Trayhurn and Wood, 2004), ageing of the immune system (Licastro 
et al., 2005) and the accumulation of senescent cells which have a pro inflammatory secretory profile 
(Freund et al., 2010). Any form of tissue damage that occurs during trauma will generate a sterile 
inflammatory response ( Zhang et al., 2010; Lord et al., 2014) and in the case of some injuries such as 
burns this persists at a low level for many years (Jeschke et al., 2011). This increased and chronic 
inflammatory burden may well contribute to accelerating the ageing process.  
Inflammation has been shown to increase the number of DNA lesions present within a tissue as a 
direct result of the increase in reactive oxygen (ROS) and nitrogen species (RNS) present during chronic 
inflammation (Meira et al., 2008). Trauma which often includes significant blood loss and then tissue 
reperfusion injury after restoration of blood volume, leads to extended ischaemia in body tissues 
which in turn generates ROS and RNS and leads to damage to mitochondrial DNA with long lasting 
impact on mitochondrial function (Papadopoulos et al., 2013; Ruchko et al., 2005).  This is one possible 
mechanism for accelerating the ageing process after trauma as dysregulated mitochondrial function 
has also been described as a hallmark of ageing (Lopez-Otin et al., 2013). 
3.2 Shortened Telomeres and trauma 
Telomere length is frequently used as a biomarker of ageing (Mather et al., 2011). Telomeres are 
hexameric repeats that aid in maintaining genomic integrity and ‘cap’ the ends of the chromosomes 
to reduce the risk of the coding portion of the genome being exposed. Due to the sequence being 
incompletely replicated during each cellular division, the length of a telomere is shortened with each 
cell divisions and can be used to establish the relative biological age of a cell. Shortened telomere 
length has been shown to be associated with increased risk of disease (Blackburn et al., 2015) and 
mortality (Cawthon et al., 2003). It is worth mentioning that while telomere length has for a long time 
been a standard biomarker for cellular ageing, the reliability of telomere length alone as a marker for 
organismal ageing is in doubt as many studies have shown an inconsistent link between telomere 
length and many aspects of the ageing process in humans (Sanders and Newman, 2013). 
Within the literature the evidence is inconsistent regarding the impact of trauma on telomere length. 
Some studies have concluded that PTSD has a significant impact on telomere attrition (Kim et al., 
2017), while others have reported  telomere elongation in trauma victims (Boks et al., 2015). However, 
in two recent meta-analyses, one of which was focused on PTSD (X. Li et al., 2017) and one on the long 
term impact of childhood trauma (Z. Li et al., 2017), both concluded that these stressors were 
associated with significant telomere shortening. It is worth mentioning that there are multiple co-
factors such as substance abuse which are commonly associated with childhood trauma and PTSD 
generally (De Bellis, 2002). These factors may also contribute to prematurely shortened telomeres 
making it difficult to attribute any telomere attrition purely to the presence of trauma and subsequent 
PTSD. 
The little research that has been done on the impact of physical traumatic injury is in repeat mild 
traumatic brain injury models in rats, which showed telomere shortening was associated with brain 
injury confirmed by MRI (Wright et al., 2018). So while there is evidence to suggest that telomere 
shortening is present to some degree following both emotional and physical trauma, there is clearly a 
major research gap which needs to be filled by clinical studies. 
Again it is likely that inflammation contributes to a reduction in telomere length as telomere attrition 
has been associated with systemic and chronic inflammation (D’Aiuto et al., 2010; Masi et al., 2011). 
While the exact relationship between inflammation and telomere shortening is yet to be fully 
understood, it is likely that they have a bi-directional influence (Kordinas et al., 2016). Damaged tissue 
itself has been shown to have reduced telomerase activity, decreased telomere length and increased 
ROS production (Felice et al., 2009). These changes are known to contribute to an inflammatory 
phenotype and potentially accelerate the ageing process both locally and systemically.  
3.3 Cellular senescence and trauma 
Cell senescence, while synonymous with ageing, is also a vital mechanism used to prevent 
tumorigenesis in cells which reach their replicative limit or have damaged DNA (Childs et al., 2015). 
Senescent cells remain metabolically active and secrete growth factors (VEGF), matrix 
metalloproteinases and proinflammatory cytokines, termed the Senescence Associated Secretory 
Phenotype (SASP) (Freund et al., 2010). Importantly animal studies have shown that deleting 
senescent cells extends lifespan, improves tissue quality and reduces a broad range of age-related 
diseases (Naylor et al., 2013), confirming the build-up of senescent cells and the associated SASP-
related inflammation as a key driver of ageing.  
Senescent cells are not exclusively negative for human health, as well as being anti-oncogenic they 
may also have evolved for their role in wound healing. Inflammation is important for recruitment of 
immune cells required to prevent infection after tissue injury, but the SASP also contains factors 
required to limit fibrosis and scarring, notably  PDGFaa (Demaria et al., 2014). Fibroblasts are present 
at wound sites during healing to replace damaged skin and secrete the extracellular matrix found in 
fibrotic scar tissue. Cellular senescence is the mechanism by which excessive fibroblast proliferation 
is prevented (Soto-Gamez and Demaria, 2017) and mice deficient in senescent cells show 
compromised wound healing (Demaria et al., 2014), but the unintended consequence may well be an 
increased burden of senescent cells in trauma survivors, contributing to acceleration of the ageing 
process. Although senescent cells can be removed by immune cells such as NK cells (Sagiv and 
Krizhanovsky, 2013), they can induce senescence in neighbouring cells (Passos et al., 2010) thus 
propagating the initial generation of senescent cells if they are not removed promptly. 
However, increased senescent cell burden in trauma patients has not yet been demonstrated and 
represents a further significant knowledge gap.  
4. Measuring the age accelerating effects of trauma in its totality through epigenetics   
There are a myriad of potential biomarkers for monitoring the progression of the ageing process, such 
as the panel of ‘healthy ageing biomarkers’ proposed by Lara et al (Lara et al., 2015), and those 
discussed thus far. Theses combinations of markers which characterise physical function, 
inflammatory cytokines and cellular characteristics while valid, offer a limited insight in to how well 
someone is ageing as a whole. Until recently there was no method of measuring complete, non-tissue 
dependent ageing but this problem is being overcome by the burgeoning field of epigenetics.  
Epigenetics describes any modification to DNA which does not affect the DNA sequence itself. Of 
specific interest with regards to ageing is the epigenetic modification known as DNA methylation 
which is the addition of a methyl group, usually to a cytosine base. DNA methylation is also arguably 
the most well studied and characterised form of epigenetic modification. DNA methylation’s role is to 
regulate gene expression. Increased methylation within the promotor region of a gene has been 
shown to reduce expression (Suzuki and Bird, 2008). While the exact mechanism responsible for 
reducing expression is yet to be fully characterised, it is currently believed that the methyl groups 
attached to the phosphate backbone of the DNA prevent transcription factors from successfully 
binding, hence preventing transcription (Medvedeva et al., 2014). Secondly it has been shown that 
increased levels of methylation within the gene body increases gene expression (Yang et al., 2014). 
Again, the exact mechanism by which this modification encourages expression is not fully understood. 
The methylome gradually becomes dysregulated as we age, known as ‘epigenetic drift’. This ‘drift’ 
occurs as methyl groups are erroneously added or removed which may be due to mutation, repair or 
failure to copy the methylation pattern during replication. As well as affecting the gene expression 
profile of an individual, their levels of ‘epigenetic drift’ can be used to accurately predict their 
chronological age. This epigenetic age prediction is most commonly done using the ‘epigenetic clock’ 
algorithm (Horvath, 2013). By using this highly accurate epigenetic clock (r=0.96) it is possible to 
estimate biological age, which when compared to the persons actual chronological age, reveals the 
rate at which ageing is occurring. We can surmise that an advanced epigenetic age represents 
advanced biological ageing and may also be a driving factor in the ageing process as many diseases 
which show accelerated epigenetic age also exhibit an ageing phenotype. These include Down’s 
syndrome (Horvath et al., 2015a), obesity (Horvath et al., 2014) and HIV infection (Horvath and Levine, 
2015).   
Interestingly, those who live into the extreme upper percentile of human life expectancy (100+ years) 
tend to show a decelerated rate of epigenetic ageing (Horvath et al., 2015b). It isn’t yet clear if a 
preserved methylome is what has contributed to their longevity or is a by-product of other processes 
such as DNA repair being well maintained during the ageing process. A recent meta-analysis of studies 
of time to death predictions based on DNA methylation concluded that epigenetic regulation plays a 
role in longevity (Chen et al., 2016). 
4.1 What we know so far about the impact of trauma on the epigenetic clock  
At this time there is currently no literature describing the impact of physical trauma on epigenetic 
ageing as measured by the Horvath epigenetic clock algorithm. There are however a growing number 
of studies reporting how emotional/psychological trauma appears to be accelerating the ageing 
process.  
The few studies in this area have focussed mainly upon PTSD. The current literature shows that just 
like physical trauma, psychological trauma also has a negative impact on mortality and health 
outcomes. Adults which have been exposed to 6 or more ‘adverse childhood experiences’ (ACEs) lived 
on average 20 years less than age-matched controls who reported no ACEs (Brown et al., 2009). This 
significant decrease in life expectancy may be due in part to the poorer mental health outcomes of 
people who experience a traumatic childhood (i.e, schizophrenia, depression, self-harm), which in turn 
is associated with an increased risk of behaviour based mortality (Hiroeh et al., 2001). Psychological 
trauma and PTSD also have an association with increased risk of disease, including classically age-
related conditions such as cardiovascular disease (Dedert et al., 2010), as well as increased levels of 
inflammation (Baumeister et al., 2016). Recent research has now shown evidence of epigenetic age 
acceleration which may go some way to explaining the early onset of age associated diseases and 
increased risk of mortality following trauma.  
One study used a cohort of 339 genotyped, non-Hispanic white military veterans with a median age 
of 52.5 years who had previously completed a PTSD assessment. The researchers found that while 
overall PTSD severity was not associated with an accelerated epigenetic age, experiencing certain 
symptoms, specifically ‘hyperarousal’ was associated with an accelerated DNA methylation age, which 
in turn was associated with reduced survival (E. J. Wolf et al., 2017a). In a meta-analysis of 
psychological trauma and its association with epigenetic age acceleration there was a small but 
significant increase in epigenetic age overall linked to childhood trauma and PTSD (E J. Wolf et al., 
2017b). While this meta-analysis does not offer a mechanistic insight into what is driving the ageing 
process forward, it does lend credence to the proposal that biological stress may accelerate the ageing 
process.  
What the literature has undoubtably shown is that ageing, disease and biological stress are inexorably 
linked. It has been established that both biological stress, whether inflammation or adverse conditions 
and diseases, are linked in some way to accelerated ageing.  
5. Trauma and ageing, commonalities and differences  
While it may be the case that both ageing and trauma share multiple pathogenic mechanisms, as 
outlined in Table 1 there are also some notable differences that largely relate to the scale and kinetic 
of the disturbance. For example, the extensive tissue damage and risk of multiple organ dysfunction 
(Durham et al., 2003) associated with a physical traumatic injury are not seen in physiological ageing 
though there is a gradual decline in many body systems resulting in multimorbidity (Ryan et al., 2015). 
Functional decline is thus a feature of both and a specific shared characteristic is sarcopenia, which is 
driven by several factors including physical inactivity and inflammation (Bano et al., 2017; Parry and 
Puthucheary, 2015). 
 In relation to inflammation, another feature of trauma and ageing, the level and chronicity of this 
increase in is drastically different. In trauma systemic inflammation is very high and at a level similar 
to a major infection (Lu et al., 2009; Namas et al., 2009) and the onset is sudden, whereas the 
inflammation associated with the ageing process is at a low level, only 2-4 fold that seen in young 
adults, and is chronic persisting potentially for decades (Bartlett et al., 2012; Franceschi et al., 2007). 
It is worth mentioning however that low level chronic inflammation does occur following some injuries 
such as burns, here chronic low grade inflammation can persist for years in a similar way to the chronic 
inflammation we classically associate with ageing (Jeschke et al., 2011).  
The accumulation of senescent cells, something classically associated with ageing, also occurs 
following trauma, although similar to inflammation the scale and timeframe of this accumulation 
differs. Following trauma, there is an increase in the presence of senescent cells near the injury site, 
which aids in tissue repair (Deursen, 2014), with ageing the increasing number of senescent cells is 
not tissue specific and occurs globally at a gradual rate (Burton, 2009).  
Here, we posit not that both age and trauma related physiological changes are identical, rather that 
they share some common mechanisms and their magnitude and kinetics differ but achieve the same 
end – a predisposition to an aged phenotype. Furthermore it bears mentioning some of the gaps in 
our understanding of the relationship between trauma and ageing and limitations in the existing data. 
Ideally there would be multiple studies within the literature examining the effect of trauma on 
multiple biomarkers of ageing (Horvath, 2013; Lara et al., 2015) in healthy adults of all ages with no 
confounding comorbidities or health behaviours. Due to the nature of trauma research, this is not the 
case. Many of the cohorts who feature in the studies described are heterogeneous, of differing 
ethnicity, injury severity, BMI and comorbidities. Many of the people enrolled into trauma research 
studies may already be showing many of the symptoms we associate with ageing prior to their injury, 
particularly the frail older patient whose injury may well be the result of a fall. In the case of the 
younger patient their injury may be the result of, or lead to, risky lifestyle behaviours such as substance 
abuse. Therefore more clinical work is needed to assess the influence these cofactors have on the 
relationship between trauma and ageing.    
6. Conclusions and future directions 
Outlined throughout this review are the long-term health consequences of major trauma for survivors 
of both physical and psychological trauma, including shortened lifespan and increased risk of early 
onset of age-related diseases. At the clinical level this would support our contention that trauma 
accelerates the ageing process and certainly processes known to drive the ageing phenotype, such as 
chronic systemic inflammation, compromised mitochondrial function do appear to be increased after 
trauma. However further research is required to test this concept at the cellular and molecular level 
with reliable and quantitative biomarkers of biological ageing. Here an analysis of DNA methylation 
for specific genomic regions associated with ageing to give ‘a biological age’ versus chronological age 
following trauma holds promise, but the studies in PTSD need to be extended and research in to 
physical trauma and DNA methylation are required. In addition, the use of a broad panel of more 
conventional blood-based biomarkers of ageing such as those outlined by Lara et al, would also be 
informative (Lara et al., 2015). 
The benefit of knowing if ageing is accelerated after trauma is not merely to expand our understanding 
of the consequences of trauma. The field of biogerontology has now advanced to such a stage that 
anti-ageing therapeutics are now in clinical trials to delay the onset or progress of age-related 
diseases. Many of these are repurposed drugs such as metformin, which affect core ageing processes 
and are able to delay ageing in a variety of species (Podhorecka et al., 2017), or drugs that target 
senescent cells, termed senolytics (Kirkland et al., 2017). In this way we may be able to improve long 
term outcomes for survivors of major trauma.  
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Table 1  
Characteristic Presence in Trauma Presence in Ageing Shared Characteristic 
Inflammation Acute, high level 
inflammation (Lu et 
al., 2009; Namas et 
al., 2009) 
Chronic low level 
inflammation (Franceschi, 
2008) 
Chronic inflammation in burn injury 
(Jeschke et al., 2008) 
 
Functional 
decline in 
organ 
systems 
 
 
Multiple organ 
dysfunction (Durham 
et al., 2003) 
 
Gradual decline in many 
body systems over time; 
multimorbidity (Ryan et 
al., 2015) 
 
Reduced lean body mass, (Bano et al., 
2017; Morley et al., 2010; Parry and 
Puthucheary, 2015) fatigue; disability 
(Evans et al., 2003; WHO, 2011) 
Immune 
compromise 
Acute 
immuneparesis and 
increased 
susceptibility to 
infection and sepsis 
(Hietbrink et al., 
2006) 
Immune remodelling with 
broad compromise to 
immunity (Dorshkind et 
al., 2009) 
Reduced neutrophil function (Butcher 
et al., 2001; Hampson et al., 2017); 
increased risk of infection 
 
DNA 
alterations 
 
Acute and large scale 
genomic change 
(Xiao et al., 2011) 
  
Genome instability 
(Moskalev et al., 2013) 
 
Epigenetic alterations after 
psychological trauma (E J. Wolf et al., 
2017b) and with age (Horvath, 2013); 
Telomere attrition (Jiang et al., 2007; X. 
Li et al., 2017; Z. Li et al., 2017) 
 
Metabolic 
disturbance 
 
Acute Increase in 
catabolism (Jeschke 
et al., 2008) 
 
Insulin resistance due to 
changes in body 
composition (Karakelides 
et al., 2010), anabolic 
resistance (Roubenoff, 
2003) 
 
Long term metabolic disturbance after 
burn – catabolism (Hart et al., 2000), 
insulin resistance (Williams et al., 2009) 
 
Cell 
senescence 
 
Acute Senescence 
(Deursen, 2014) 
 
Increase in cell senescence 
over time (Velarde and 
Demaria, 2016) 
  
Senescent cells primarily at wound site 
(Campisi, 2005; Deursen, 2014) 
 
Table 1: Features present in trauma and ageing and the characteristics they share.  
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